Roflumilast succeeds where traditional therapy fails: a case report

https://doi.org/10.4081/monaldi.2013.30

Authors

  • Gabriella Guarnieri | gabriella.guarnieri@unipd.it Occupational Medicine, Respiratory Pathophysiology Laboratory; Department of Cardiologic, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.

Abstract

The case of a 72-year-old man with a long history of chronic obstructive pulmonary disease (COPD, patient D according to Guidelines GOLD 2013) in a subject professionally exposed to welding fumes is presented. Diagnosis was based on symptoms and spirometry and confirmed by chest X-ray examination. Since 1997 the patient has been under different therapies, including high-dose inhaled corticosteroids and bronchodilators, with poor clinical control and frequent exacerbations. Roflumilast 500 μg once daily was started in January 2012 and patient’s respiratory symptoms, number of exacerbations and spirometry values have gradually improved since then. Roflumilast was an effective treatment in this case of difficult to treat severe COPD.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Downloads

Published
2015-08-19
Keywords:
Roflumilast, COPD, Case report
Statistics
  • Abstract views: 469

  • PDF: 458
How to Cite
Guarnieri, Gabriella. 2015. “Roflumilast Succeeds Where Traditional Therapy Fails: A Case Report”. Monaldi Archives for Chest Disease 79 (3-4). https://doi.org/10.4081/monaldi.2013.30.

Similar Articles

You may also start an advanced similarity search for this article.